U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C8H6N2
Molecular Weight 130.1466
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PHTHALAZINE

SMILES

C1=CC=C2C=NN=CC2=C1

InChI

InChIKey=LFSXCDWNBUNEEM-UHFFFAOYSA-N
InChI=1S/C8H6N2/c1-2-4-8-6-10-9-5-7(8)3-1/h1-6H

HIDE SMILES / InChI

Molecular Formula C8H6N2
Molecular Weight 130.1466
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Design and synthesis of selective and potent orally active S1P5 agonists.
2010-10-04
Augmentation of the antileukemia potency of total-body irradiation (TBI) by a novel P-site inhibitor of spleen tyrosine kinase (SYK).
2010-10
Associative and dissociative mechanisms in the formation of phthalazine bridged organodiplatinum(II) complexes.
2010-09-20
Discovery of a potent, selective, and orally bioavailable pyridinyl-pyrimidine phthalazine aurora kinase inhibitor.
2010-09-09
Addressing PXR liabilities of phthalazine-based hedgehog/smoothened antagonists using novel pyridopyridazines.
2010-08-01
Synthesis and antitumor activities of novel 1,4-disubstituted phthalazine derivatives.
2010-08
2-[1-(3-Oxo-1,3-dihydro-2-benzofuran-1-yl)-1H-benzimidazol-2-yl]benzoic acid methanol solvate.
2010-07-17
Development of improved models for phosphodiesterase-4 inhibitors with a multi-conformational structure-based QSAR method.
2009-12-31
4-Hydr-oxy-6-[(4-hydr-oxy-1-oxo-1,2-dihydro-phthalazin-6-yl)carbon-yl]phthalazin-1(2H)-one.
2009-11-11
Phthalocyanine-C60 fused conjugates exhibiting molecular orbital interactions depending on the solvent polarity.
2009-11-02
Synthesis and antibacterial activity of some new heterocycles incorporating phthalazine.
2009-11
3-Methyl-1,2,4-triazolo[3,4-a]phthalazine monohydrate.
2009-10-10
Novel phthalazinyl derivatives: synthesis, antimycobacterial activities, and inhibition of Mycobacterium tuberculosis isocitrate lyase enzyme.
2009-09
Evaluation of solvent effects on protonation using NMR spectroscopy: implication in salt formation.
2009-07-30
Dichloridobis(phenanthridine-κN)zinc(II).
2009-06-06
Theoretical quest for photoconversion molecules having opposite directions of the electric dipole moment in S0 and S1 states.
2009-05-14
2-(3-Oxo-1,3-dihydro-isobenzofuran-1-yl)-phthalazin-1(2H)-one.
2009-04-08
S(N)(H) approach in the synthesis of nitronyl nitroxides.
2009-04-03
Ultrasound assisted reactions of steroid analogous of anticipated biological activities.
2009-03
Practical synthesis of a p38 MAP kinase inhibitor.
2009-01-16
Microwave assisted reactions of some azaheterocylic compounds.
2009-01-15
Site directed mutagenesis of amino acid residues at the active site of mouse aldehyde oxidase AOX1.
2009
A new structure-based QSAR method affords both descriptive and predictive models for phosphodiesterase-4 inhibitors.
2008-11-06
Discovery of highly selective and potent p38 inhibitors based on a phthalazine scaffold.
2008-10-23
Structural basis for ligand recognition at the benzodiazepine binding site of GABAA alpha 3 receptor, and pharmacophore-based virtual screening approach.
2008-10
Synthesis of 3,4-benzo-7-hydroxy-2,9-diazabicyclo[3.3.1]non-7-enes by cyclization of 1,3-bis(silyl enol ethers) with quinazolines.
2008-08-21
Multiple surface plasmon resonances and near-infrared field enhancement of gold nanowells.
2008-07-01
A new class of luminescent tricarbonyl rhenium(I) complexes containing bridging 1,2-diazine ligands: electrochemical, photophysical, and computational characterization.
2008-05-19
Conformation-activity relationship on novel 4-pyridylmethylthio derivatives with antiangiogenic activity.
2008-05-01
N,N'-Bis(4-chloro-phen-yl)urea.
2008-04-26
Synthesis of 1-/2-substituted-[1,2,3]triazolo[4,5-g]phthalazine-4,9-diones and evaluation of their cytotoxicity and topoisomerase II inhibition.
2008-04-15
Role of phosphodiesterase 5 in synaptic plasticity and memory.
2008-04
2-(2-Hydroxy-ethyl)phthalazin-1(2H)-one.
2008-03-29
(1R,2R)-4-Benzoyl-2-benzo-yloxy-1-phenyl-butyl imidazole-1-carboxyl-ate.
2008-02-22
(2S,4'R,5'R)-(E)-tert-Butyl 2-acetyl-2-(2-oxo-5-phenyl-1,3-dioxolan-4-ylmeth-yl)-5-phenyl-pent-4-enoate.
2008-01-30
Phthalazin-1(2H)-one-picric acid (1/1).
2007-12-06
Copper(I) cyanide networks: synthesis, luminescence behavior and thermal analysis. Part 1. Diimine ligands.
2007-10-15
Efficiency improvement for sulfated ash determination by usage of a microwave muffle furnace.
2007-04-11
[Synthesis and characterization of silver-intermediates in the development process of photothermographic material].
2007-04
1,4-Bis(alkylamino)benzo[g]phthalazines able to form dinuclear complexes of Cu(II) which as free ligands behave as SOD inhibitors and show efficient in vitro activity against Trypanosoma cruzi.
2007-03-01
Luminescent hydrido-carbonyl clusters of rhenium containing bridging 1,2-diazine ligands.
2006-12-25
4-(Azolylphenyl)-phthalazin-1-amines: Novel inhibitors of VEGF receptors I and II.
2006-12
1-(Azolyl)-4-(aryl)-phthalazines: novel potent inhibitors of VEGF receptors I and II.
2006-11
A dinucleating ligand related to the beta-diketiminates.
2006-08-28
Evaluation of apoptosis-induction by newly synthesized phthalazine derivatives in breast cancer cell lines.
2006-07-15
Aqueous N-heterocyclization of primary amines and hydrazines with dihalides: microwave-assisted syntheses of N-azacycloalkanes, isoindole, pyrazole, pyrazolidine, and phthalazine derivatives.
2006-01-06
Oxidative addition of methyl iodide to a new type of binuclear platinum(II) complex: a kinetic study.
2005-11-14
Arylphthalazines: identification of a new phthalazine chemotype as inhibitors of VEGFR kinase.
2005-11-01
VEGF receptor kinase inhibitors: phthalazines, anthranilamides and related structures.
2005-06
Prediction of genotoxicity of chemical compounds by statistical learning methods.
2005-06
Patents
Substance Class Chemical
Created
by admin
on Wed Apr 02 19:42:22 GMT 2025
Edited
by admin
on Wed Apr 02 19:42:22 GMT 2025
Record UNII
91Y28DM24N
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NSC-62484
Preferred Name English
PHTHALAZINE
MI  
Systematic Name English
PHTHALAZINE [USP IMPURITY]
Common Name English
PHTHALAZINE [USP-RS]
Common Name English
PHTHALAZINE [MI]
Common Name English
Code System Code Type Description
FDA UNII
91Y28DM24N
Created by admin on Wed Apr 02 19:42:22 GMT 2025 , Edited by admin on Wed Apr 02 19:42:22 GMT 2025
PRIMARY
MESH
C043388
Created by admin on Wed Apr 02 19:42:22 GMT 2025 , Edited by admin on Wed Apr 02 19:42:22 GMT 2025
PRIMARY
EPA CompTox
DTXSID9049407
Created by admin on Wed Apr 02 19:42:22 GMT 2025 , Edited by admin on Wed Apr 02 19:42:22 GMT 2025
PRIMARY
MERCK INDEX
m8752
Created by admin on Wed Apr 02 19:42:22 GMT 2025 , Edited by admin on Wed Apr 02 19:42:22 GMT 2025
PRIMARY Merck Index
WIKIPEDIA
PHTHALAZINE
Created by admin on Wed Apr 02 19:42:22 GMT 2025 , Edited by admin on Wed Apr 02 19:42:22 GMT 2025
PRIMARY
CAS
253-52-1
Created by admin on Wed Apr 02 19:42:22 GMT 2025 , Edited by admin on Wed Apr 02 19:42:22 GMT 2025
PRIMARY
SMS_ID
100000156989
Created by admin on Wed Apr 02 19:42:22 GMT 2025 , Edited by admin on Wed Apr 02 19:42:22 GMT 2025
PRIMARY
EVMPD
SUB131098
Created by admin on Wed Apr 02 19:42:22 GMT 2025 , Edited by admin on Wed Apr 02 19:42:22 GMT 2025
PRIMARY
RS_ITEM_NUM
1535959
Created by admin on Wed Apr 02 19:42:22 GMT 2025 , Edited by admin on Wed Apr 02 19:42:22 GMT 2025
PRIMARY
PUBCHEM
9207
Created by admin on Wed Apr 02 19:42:22 GMT 2025 , Edited by admin on Wed Apr 02 19:42:22 GMT 2025
PRIMARY
CHEBI
36597
Created by admin on Wed Apr 02 19:42:22 GMT 2025 , Edited by admin on Wed Apr 02 19:42:22 GMT 2025
PRIMARY
NSC
62484
Created by admin on Wed Apr 02 19:42:22 GMT 2025 , Edited by admin on Wed Apr 02 19:42:22 GMT 2025
PRIMARY
ECHA (EC/EINECS)
205-963-2
Created by admin on Wed Apr 02 19:42:22 GMT 2025 , Edited by admin on Wed Apr 02 19:42:22 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP